Published in Antimicrob Agents Chemother on September 01, 1976
Biochemistry and clinical applications of ribavirin. Antimicrob Agents Chemother (1986) 1.72
Double-blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers. Antimicrob Agents Chemother (1977) 1.70
Effects of ribavirin on respiratory syncytial virus in vitro. Antimicrob Agents Chemother (1980) 1.28
Continuous aerosol therapy system using a modified Collison nebulizer. J Clin Microbiol (1977) 1.23
In vivo inhibition of respiratory syncytial virus by ribavirin. Antimicrob Agents Chemother (1982) 1.10
Response of influenza virus-infected mice to selected doses of ribavirin administered intraperitoneally or by aerosol. Antimicrob Agents Chemother (1977) 1.05
Activity of amantadine, rimantadine, and ribavirin against swine influenza in mice and squirrel monkeys. Antimicrob Agents Chemother (1978) 0.91
Evaluation of carbodine, the carbocyclic analog of cytidine, and related carbocyclic analogs of pyrimidine nucleosides for antiviral activity against human influenza Type A viruses. Antimicrob Agents Chemother (1981) 0.90
Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead. Adv Drug Deliv Rev (2014) 0.87
Effects of small-particle aerosols of rimantadine and ribavirin on arterial blood pH and gas tensions and lung water content of A2 influenza-infected mice. Antimicrob Agents Chemother (1977) 0.75
Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. J Med Chem (1972) 4.12
In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob Agents Chemother (1973) 4.04
Modifications to the Henderson apparatus for studying air-borne infections. Evaluations using aerosols of Listeria monocytogenes. J Infect Dis (1962) 2.00
Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice. Antimicrob Agents Chemother (1973) 1.87
Studies in experimental immunology of influenza. IV. The protective value of active immunization. Aust J Exp Biol Med Sci (1950) 1.60
Small-particle aerosols of antiviral compounds in treatment of type A influenza pneumonia in mice. J Infect Dis (1976) 1.56
Efficacy of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide against influenza virus infections in mice. Antimicrob Agents Chemother (1975) 1.56
Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals. Antimicrob Agents Chemother (1973) 1.42
Treatment of influenza infection of mice by using rimantadine hydrochlorides by the aerosol and intraperitoneal routes. Antimicrob Agents Chemother (1975) 1.34
Responses of mice immunized with influenza virus by serosol and parenteral routes. Infect Immun (1976) 1.11
Influenza virus epidemics: A continuing problem. Geriatrics (1974) 1.03
Aerosol evaluations of the DeVilbiss No. 40 and Vaponefrin nebulizers. Appl Environ Microbiol (1976) 1.00
Mechanism of action of anti-influenza benzamidine derivatives. Antimicrob Agents Chemother (1975) 0.97
Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis (1980) 2.38
Plaque assay for Ebola virus. J Clin Microbiol (1981) 1.99
Urinary ascariasis in a man with hematuria. South Med J (2001) 1.92
Neurological and physiological responses of the primate to anthrax toxin. J Infect Dis (1968) 1.88
Influenza alone and in sequence with pneumonia due to Streptococcus pneumoniae in the squirrel monkey. J Infect Dis (1975) 1.88
A year's experience of functional budgeting in a clinical department. Anaesthesia (1981) 1.72
Electron microscopic study on the interaction between normal guinea pig peritoneal macrophages and Coxiella burnetii. Infect Immun (1976) 1.65
Small-particle aerosols of antiviral compounds in treatment of type A influenza pneumonia in mice. J Infect Dis (1976) 1.56
Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator. Antiviral Res (1986) 1.55
Clinical and clinicopathologic findings in tropical canine pancytopenia. J Am Vet Med Assoc (1970) 1.54
Role of the lymphatics in the pathogenesis of anthrax. J Infect Dis (1965) 1.52
Pathophysiology of anthrax. J Infect Dis (1966) 1.52
Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs. Infect Immun (1981) 1.51
Value of field data for extrapolation in anthrax. Fed Proc (1967) 1.48
Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys. Antimicrob Agents Chemother (1981) 1.47
Effect of environmental factors on aerosol-induced Lassa virus infection. J Med Virol (1984) 1.47
Tropical canine pancytopenia. J Am Vet Med Assoc (1970) 1.43
Influenza virus population dynamics in the respiratory tract of experimentally infected mice. Infect Immun (1976) 1.43
Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanamycin. Antimicrob Agents Chemother (1975) 1.43
Cost of anaesthesia. Br Med J (Clin Res Ed) (1982) 1.40
Interaction between Coxiella burnetii and guinea pig peritoneal macrophages. Infect Immun (1976) 1.40
Treatment of influenza infection of mice by using rimantadine hydrochlorides by the aerosol and intraperitoneal routes. Antimicrob Agents Chemother (1975) 1.34
Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. J Infect Dis (1984) 1.30
Pathophysiological changes in the rat associated with anthrax toxin. J Infect Dis (1968) 1.30
Serological relation between Rift Valley fever virus and viruses of phlebotomus fever serogroup. Lancet (1980) 1.29
Functional and morphologic changes during experimental Rocky Mountain spotted fever in guinea pigs. Lab Invest (1976) 1.28
Evaluation of two monkey species (Macaca mulatta and Macaca fascicularis) as possible models for human Helicobacter pylori disease. J Clin Microbiol (1990) 1.27
Modified spinning top homogeneous spray apparatus for use in experimental respiratory disease studies. Appl Microbiol (1974) 1.27
Cost of anaesthetic drugs and clinical budgeting. Br Med J (Clin Res Ed) (1986) 1.26
Human leucocyte antigens in Crohn's disease and ulcerative colitis. Gut (1972) 1.26
A precise method for replicating suspension cultures of mammalian cells. Appl Microbiol (1968) 1.23
Continuous aerosol therapy system using a modified Collison nebulizer. J Clin Microbiol (1977) 1.23
Intranasal infection of monkeys with Japanese encephalitis virus: clinical response and treatment with a nuclease-resistant derivative of poly (I).poly (C). Am J Trop Med Hyg (1977) 1.22
Lymphocyte reactivity in pregnancy. Br Med J (1972) 1.21
Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus. Infect Immun (1981) 1.19
Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta). J Infect Dis (1977) 1.19
Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters. Infect Immun (1977) 1.18
Fat of Coxiella burnetti in macrophages from immune guinea pigs. Infect Immun (1977) 1.16
Enzyme-linked immunosorbent assay for detection of antibodies to Rift Valley fever virus in ovine and bovine sera. Am J Vet Res (1987) 1.15
Inactivated vaccine for Ebola virus efficacious in guineapig model. Lancet (1980) 1.14
Abortion in vaccinated sheep and cattle after challenge with Rift Valley fever virus. Vet Rec (1981) 1.13
Immune response of steers, goats and sheep to inactivated Rift Valley Fever vaccine. Proc Annu Meet U S Anim Health Assoc (1979) 1.11
Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant. Infect Immun (1976) 1.09
Pathology of canine ehrlichiosis (tropical canine pancytopenia). Am J Vet Res (1973) 1.08
In vivo growth and distribution of anthrax bacilli in resistant, susceptible, and immunized hosts. J Bacteriol (1967) 1.07
Protective and toxic effects of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid on Venezuelan equine encephalomyelitis virus in rhesus monkeys. J Infect Dis (1979) 1.07
Pharmacokinetic-pharmacodynamic relationships of morphine in neonates. Clin Pharmacol Ther (1992) 1.05
Pathophysiological and biochemical changes in anthrax. Fed Proc (1967) 1.05
Involvement of small mammals in the transmission of scrub typhus in Malaysia: isolation and serological evidence. Trans R Soc Trop Med Hyg (1973) 1.05
Response of influenza virus-infected mice to selected doses of ribavirin administered intraperitoneally or by aerosol. Antimicrob Agents Chemother (1977) 1.05
Attempts to infect and demonstrate transovarial transmission of R. tsutsugamushi in three species of Leptotrombidium mites. Ann N Y Acad Sci (1975) 1.05
Pathogenesis of tularemia in immune and nonimmune rats. Am J Vet Res (1975) 1.04
Swine influenza virus vaccine: potentiation of antibody responses in rhesus monkeys. Science (1977) 1.03
Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early disease. Clin Exp Immunol (2001) 1.02
Relationship of serum beta-glucuronidase and lysozyme to pathogenesis of tularemia in immune and nonimmune rats. Infect Immun (1975) 1.01
Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex. Antimicrob Agents Chemother (1977) 1.01
Immunoglobulin-bearing cells in lungs of mice infected with influenza virus. Infect Immun (1976) 1.00
Aerosol therapy of influenza infections of mice and primates with rimantadine, ribavirin, and related compounds. Ann N Y Acad Sci (1977) 1.00
Aerosol evaluations of the DeVilbiss No. 40 and Vaponefrin nebulizers. Appl Environ Microbiol (1976) 1.00
Hematological and bone marrow effects of ribavirin in rhesus monkeys. Toxicol Appl Pharmacol (1984) 1.00
Experimental Lassa fever virus infection successfully treated with ribavirin. Lancet (1979) 0.99
Induced metabolic sequelae of tularemia in the rat: correlation with tissue damage. Am J Physiol (1975) 0.99
Neurological and physiological responses of the primate to anthrax infection. J Infect Dis (1968) 0.97
Prophylactic oral antibiotics for low-risk dog bite wounds. Pediatr Emerg Care (1992) 0.96
Filter paper collection of blood for use in a screening and diagnostic test for scrub typhus using the IFAT. Trans R Soc Trop Med Hyg (1972) 0.94
Hyperalgesia due to nerve damage: role of nerve growth factor. Pain (1999) 0.94
Does fever or myalgia indicate reduced physical performance capacity in viral infections? Acta Med Scand (1985) 0.93
Aerosol stability and respiratory infectivity of japanese B encephalitis virus. Infect Immun (1980) 0.93
Effects of nitric oxide synthase inhibition on ciliary blood flow, aqueous production and intraocular pressure. Exp Eye Res (2001) 0.93
A laboratory model for studying blast overpressure injury. J Trauma (1987) 0.92
Pathology of experimental Rocky Mountain spotted fever in rhesus monkeys. Vet Pathol (1976) 0.91
Activity of amantadine, rimantadine, and ribavirin against swine influenza in mice and squirrel monkeys. Antimicrob Agents Chemother (1978) 0.91
The effect of habitat on the prevalence of human scrub typhus in Malaysia. Trans R Soc Trop Med Hyg (1972) 0.90
Therapeutic effects of small-particle aerosols of ribavirin on parainfluenza (sendai) virus infections of mice. Antimicrob Agents Chemother (1976) 0.90
Immunological studies in acute myeloid leukaemia: PHA responsiveness and serum inhibitory factors. Br J Cancer (1973) 0.90
Indirect mouse model for the evaluation of potential antiviral compounds: results with Venezuelan equine encephalomyelitis virus. Antimicrob Agents Chemother (1977) 0.90
Effect of interferon on togavirus and arenavirus infections of animals. Tex Rep Biol Med (1977) 0.89
Effect of temperature and drug therapy on anthrax intoxication. Proc Soc Exp Biol Med (1967) 0.86
The use of acid alumina and sephadex LH-20 for the separation and characterization of ethanol-soluble peptides produced by Bacillus brevis. Biochem J (1972) 0.86
Ehrlichia canis--the causative agent of a haemorrhagic disease of dogs? Vet Rec (1969) 0.86
Evaluation of factors related to growth of Rift Valley fever virus in suspended cell cultures. Appl Microbiol (1969) 0.86
Development of hypergammaglobulinemia in tropical canine pancytopenia. Am J Vet Res (1971) 0.86
Studies of the coagulation and complement systems during experimental Rocky Mountain spotted fever in rhesus monkeys. J Infect Dis (1977) 0.86
Alterations in plasma copper, zinc, amino acids, and seromucoid during Rocky Moutain spotted fever in guinea pigs. Proc Soc Exp Biol Med (1976) 0.85
Mammals and scrub typhus ecology in peninsular Malaysia. Trans R Soc Trop Med Hyg (1975) 0.85
Rectal blowout by personal watercraft water jet: case report and review of literature. J Trauma (1999) 0.85
The in vivo effects of tumour necrosis factor blockade on the early cell mediated immune events and syndrome expression in rat adjuvant arthritis. Clin Exp Immunol (2002) 0.84
Dengue-4 vaccine: neurovirulence, viraemia and immune responses in rhesus and cynomolgus monkeys. Trans R Soc Trop Med Hyg (1988) 0.84
Gender differences in pain. Curr Opin Anaesthesiol (1999) 0.83
The neurovirulence of flaviviruses in crab-eating monkeys (Macaca fascicularis). Southeast Asian J Trop Med Public Health (1986) 0.83